Saturday, July 11, 2026

pharma · Sepsis · Tumor, Solid

Sichuan Kelun Pharmaceutical

Sichuan Provincial People's is a pharma organization headquartered in CN. Primary therapeutic focus areas include Sepsis, Tumor, Solid, Carcinoma, Non-Small-Cell Lung, Advanced Solid Tumors. NovaPharmaNews links 4 clinic

CN HQ
375 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
375
Programs
4
Drugs
6
Patents
0
Clinical program

Radiation: 18F-AlF-FAPi-04

Phase 1 · small molecule · Tumor, Solid

Radiation: 18F-AlF-FAPi-04 for Tumor, Solid is a Phase 1 program (small_molecule) at Sichuan Provincial People's Hospital with 1 ClinicalTrials.gov record(s).

Internal code TRX0109001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sichuan Provincial People's Hospital
Phase
Phase 1
Modality
small_molecule
Indication
Tumor, Solid
Status
active
Trials
1